Business
Cipher Pharmaceuticals and Italmex Pharma Announce Exclusive Distribution Agreement for Isotretinoin Product in Mexico
Cipher Pharmaceuticals and Italmex Pharma Announce Exclusive Distribution Agreement for Is...
About this update from Cipher Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCipher Pharmaceuticals and Italmex Pharma Announce Exclusive Distribution Agreement for Isotretinoin Product in Mexico\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnsbb0{\nBORDER-BOTTOM:0pt\n}\n.prnpr6{\nPADDING-RIGHT:0.50em\n}\n.prnsbr0{\nBORDER-RIGHT:0pt\n}\n.prnvab{\nVERTICAL-ALIGN: BOTTOM\n}\n.prntar{\nTEXT-ALIGN: RIGHT\n}\n.prnsbl0{\nBORDER-LEFT:0pt\n}\n.prnsblb0{\nBORDER-LEFT:black 0pt\n}\n.prnrbrb0{\nBORDER-RIGHT:black 0pt\n}\n.prntal{\nTEXT-ALIGN: LEFT\n}\n.prnsbt0{\nBORDER-TOP:0pt\n}\n.prnsbtb0{\nBORDER-BOTTOM:black 0pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnpl6{\nPADDING-LEFT:0.50em\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMISSISSAUGA, ON, Jan. 9, 2018\n\n\n\nMISSISSAUGA, ON, Jan. 9, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) today announced it has entered into an exclusive distribution and supply agreement with Italmex Pharma S.A. (\"Italmex\") under which Cipher has granted Italmex exclusive rights to market, sell and distribute Cipher's Isotretinoin product in Mexico. \n\n\"Our isotretinoin product has been a highly successful franchise for Cipher in the U.S. and Canada, and we look forward to bringing it to Mexico through our partnership with Italmex, which is a well-established specialty pharma company with a strong presence and track record in dermatology,\" said Robert Tessarolo, President and CEO of Cipher. \"This agreement is consistent with our strategy to monetize our existing licensing portfolio in other regions.\" \n\nJose Ramon Sanchez Medal, Chief Executive Officer of Italmex Pharma, stated: \"We are very pleased to enter into this agreement with Cipher, a company with a strong commitment to innovation in dermatology. This collaboration is fully aligned with our strategy to strengthen our pipeline in dermatology and expand our dermatology leadership position in Mexico through the addition of innovative products. I am proud that our company can bring this medicine to severe acne patients in Mexico to help improve their lives.\"\n\nCipher's isotretinoin product is a novel formulation of isotretinoin, which is used in the treatment of s...